<table id="ID236" width="99%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>TABLE 4. Average Pharmacokinetic Parameters of Ceftriaxone in Humans</caption>
<col span="1" width="45%"></col>
<col span="1" width="17%"></col>
<col span="1" width="18%"></col>
<col span="1" width="19%"></col>
<tbody>
<tr>
<td>Subject<br/>Group<br/>
</td>
<td>Elimination<br/>Half-Life<br/>(hr)<br/>
</td>
<td>Plasma<br/>Clearance<br/>(L/hr)<br/>
</td>
<td>Volume of<br/>Distribution<br/>(L)<br/>
</td>
</tr>
<tr>
<td>Healthy Subjects<br/>
</td>
<td>5.8-8.7<br/>
</td>
<td>0.58-1.45<br/>
</td>
<td>5.8-13.5<br/>
</td>
</tr>
<tr>
<td>Elderly Subjects (mean age, 70.5 yr)<br/>
</td>
<td>8.9<br/>
</td>
<td>0.83<br/>
</td>
<td>10.7<br/>
</td>
</tr>
<tr>
<td>Patients With Renal Impairment<br/>
</td>
<td>
<br/>
</td>
<td>
<br/>
</td>
<td>
<br/>
</td>
</tr>
<tr>
<td>  Hemodialysis Patients (0-5 L/min)*<br/>
</td>
<td>14.7<br/>
</td>
<td>0.65<br/>
</td>
<td>13.7<br/>
</td>
</tr>
<tr>
<td>  Severe (5-15 mL/min)<br/>
</td>
<td>15.7<br/>
</td>
<td>0.56<br/>
</td>
<td>12.5<br/>
</td>
</tr>
<tr>
<td>  Moderate (16-30 mL/min)<br/>
</td>
<td>11.4<br/>
</td>
<td>0.72<br/>
</td>
<td>11.8<br/>
</td>
</tr>
<tr>
<td>  Mild (31-60 mL/min)<br/>
</td>
<td>12.4<br/>
</td>
<td>0.70<br/>
</td>
<td>13.3<br/>
</td>
</tr>
<tr>
<td>Patients With Liver Disease<br/>
</td>
<td>8.8<br/>
</td>
<td>1.1<br/>
</td>
<td>13.6<br/>
</td>
</tr>
<tr>
<td>
<paragraph>*Creatinine clearance<br/>
</paragraph>
</td>
</tr>
</tbody>
</table>